Chelvey International Ltd - Sep 17, 2021 Form 4 Insider Report for Vicarious Surgical Inc. (RBOT)

Role: 10%+ Owner
Signature: /s/ June Morris, Attorney-in-Fact
Stock symbol: RBOT
Transactions as of: Sep 17, 2021
Transactions value $: $0
Form type: 4
Date filed: 10/1/2021, 06:51 PM
Next filing: Feb 2, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RBOT	Class A Common Stock	Award		+10M			10M	Sep 17, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	In connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 15, 2021, by and among D8 Holdings Corp. ("D8"), Snowball Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of D8 ("Merger Sub"), and Vicarious Surgical Inc., a Delaware corporation ("Vicarious"), pursuant to which Merger Sub merged with and into Vicarious, with Vicarious surviving as a wholly-owned subsidiary of D8 (which changed its name to "Vicarious Surgical Inc.", the "Issuer"), these shares were received in exchange for 3,043,028 Series A3 Preferred Stock of Vicarious.
F2	E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. Philip Liang is the managing partner of E15 Fund II, LP and Shrikant Patnaik is a principal of E15 Fund II, LP and may be deemed to share voting and dispositive power over the shares held by Chelvey International Limited. Such persons and entities disclaim beneficial ownership of shares held by Chelvey International Limited, except to the extent of any pecuniary interest therein.

Content

In connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 15, 2021, by and among D8 Holdings Corp. ("D8"), Snowball Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of D8 ("Merger Sub"), and Vicarious Surgical Inc., a Delaware corporation ("Vicarious"), pursuant to which Merger Sub merged with and into Vicarious, with Vicarious surviving as a wholly-owned subsidiary of D8 (which changed its name to "Vicarious Surgical Inc.", the "Issuer"), these shares were received in exchange for 3,043,028 Series A3 Preferred Stock of Vicarious.

E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. Philip Liang is the managing partner of E15 Fund II, LP and Shrikant Patnaik is a principal of E15 Fund II, LP and may be deemed to share voting and dispositive power over the shares held by Chelvey International Limited. Such persons and entities disclaim beneficial ownership of shares held by Chelvey International Limited, except to the extent of any pecuniary interest therein.